A 68-year-old man with symptomatic atrial fibrillation is started on oral amiodarone for rhythm control. Due to the medication's well-established toxicity profile, specific organ systems must be evaluated prior to initiation and periodically during long-term therapy. Which of the following tests are required for routine baseline and ongoing monitoring in this patient? (Select all that apply)
- Thyroid-stimulating hormone (TSH) levelsCevap
- Hepatic transaminase levelsCevap
- Pulmonary function testing and chest radiographyCevap
- DRoutine serum creatine kinase (CK) levels
- ESerial echocardiograms every 3 months
Cevap
The correct evaluations are thyroid-stimulating hormone (TSH) levels, hepatic transaminase levels, and pulmonary function testing with chest radiography.
Amiodarone is a highly effective antiarrhythmic but is associated with significant end-organ toxicity. It has a high iodine content and can cause both hyperthyroidism and hypothyroidism, requiring baseline and periodic thyroid-stimulating hormone (TSH) monitoring. It can also cause hepatotoxicity, necessitating regular evaluation of hepatic transaminase levels. Furthermore, amiodarone-induced pulmonary toxicity (e.g., interstitial pneumonitis) is a potentially fatal complication, making baseline chest radiography and pulmonary function testing essential.
Adım Adım Çözüm
Anahtar Kavram
Patients starting amiodarone require baseline and periodic monitoring of thyroid function (TSH), liver function (LFTs), and pulmonary function (PFTs/CXR) due to the drug's multiorgan toxicity profile.